A new trading day began on Tuesday, with Q32 Bio Inc (NASDAQ: QTTB) stock price up 16.13% from the previous day of trading, before settling in for the closing price of $2.17. QTTB’s price has ranged from $1.35 to $53.17 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 31.75% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 50.53%. With a float of $4.46 million, this company’s outstanding shares have now reached $12.20 million.
Q32 Bio Inc (QTTB) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Q32 Bio Inc is 63.42%, while institutional ownership is 15.47%. The most recent insider transaction that took place on Aug 26 ’25, was worth 18,900. In this transaction CEO of this company sold 10,494 shares at a rate of $1.80, taking the stock ownership to the 121,506 shares. Before that another transaction happened on Aug 26 ’25, when Company’s Chief Scientific Officer sold 2,990 for $1.80, making the entire transaction worth $5,385. This insider now owns 58,384 shares in total.
Q32 Bio Inc (QTTB) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -1.46 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.71 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.53% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.09% during the next five years compared to 31.75% growth over the previous five years of trading.
Q32 Bio Inc (NASDAQ: QTTB) Trading Performance Indicators
Here are Q32 Bio Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.06. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.30, a number that is poised to hit -1.19 in the next quarter and is forecasted to reach -4.38 in one year’s time.
Technical Analysis of Q32 Bio Inc (QTTB)
Let’s dig in a bit further. During the last 5-days, its volume was 0.42 million. That was inferior than the volume of 0.56 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 87.23%.
During the past 100 days, Q32 Bio Inc’s (QTTB) raw stochastic average was set at 48.86%, which indicates a significant decrease from 87.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.17 in the past 14 days, which was lower than the 0.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.89, while its 200-day Moving Average is $2.16. However, in the short run, Q32 Bio Inc’s stock first resistance to watch stands at $2.74. Second resistance stands at $2.95. The third major resistance level sits at $3.26. If the price goes on to break the first support level at $2.21, it is likely to go to the next support level at $1.90. The third support level lies at $1.68 if the price breaches the second support level.
Q32 Bio Inc (NASDAQ: QTTB) Key Stats
With a market capitalization of 30.74 million, the company has a total of 12,198K Shares Outstanding. Currently, annual sales are 0 K while annual income is -47,730 K. The company’s previous quarter sales were 0 K while its latest quarter income was -9,490 K.
